241 related articles for article (PubMed ID: 34979274)
1. Multifaceted role of chemokines in solid tumors: From biology to therapy.
Raza S; Rajak S; Tewari A; Gupta P; Chattopadhyay N; Sinha RA; Chakravarti B
Semin Cancer Biol; 2022 Nov; 86(Pt 3):1105-1121. PubMed ID: 34979274
[TBL] [Abstract][Full Text] [Related]
2. Chemokine-Directed Tumor Microenvironment Modulation in Cancer Immunotherapy.
Bule P; Aguiar SI; Aires-Da-Silva F; Dias JNR
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575965
[TBL] [Abstract][Full Text] [Related]
3. The Role of CXC Chemokine Receptors 1-4 on Immune Cells in the Tumor Microenvironment.
Susek KH; Karvouni M; Alici E; Lundqvist A
Front Immunol; 2018; 9():2159. PubMed ID: 30319622
[TBL] [Abstract][Full Text] [Related]
4. CXCL12 Signaling in the Tumor Microenvironment.
Portella L; Bello AM; Scala S
Adv Exp Med Biol; 2021; 1302():51-70. PubMed ID: 34286441
[TBL] [Abstract][Full Text] [Related]
5. Beyond Cell Motility: The Expanding Roles of Chemokines and Their Receptors in Malignancy.
Morein D; Erlichman N; Ben-Baruch A
Front Immunol; 2020; 11():952. PubMed ID: 32582148
[TBL] [Abstract][Full Text] [Related]
6. Advance in the role of chemokines/chemokine receptors in carcinogenesis: Focus on pancreatic cancer.
Song N; Cui K; Zeng L; Li M; Fan Y; Shi P; Wang Z; Su W; Wang H
Eur J Pharmacol; 2024 Mar; 967():176357. PubMed ID: 38309677
[TBL] [Abstract][Full Text] [Related]
7. Chemokines and their Receptors: Multifaceted Roles in Cancer Progression and Potential Value as Cancer Prognostic Markers.
Do HTT; Lee CH; Cho J
Cancers (Basel); 2020 Jan; 12(2):. PubMed ID: 31991604
[TBL] [Abstract][Full Text] [Related]
8. The CC and CXC chemokines: major regulators of tumor progression and the tumor microenvironment.
Bikfalvi A; Billottet C
Am J Physiol Cell Physiol; 2020 Mar; 318(3):C542-C554. PubMed ID: 31913695
[TBL] [Abstract][Full Text] [Related]
9. The immunosuppressive and pro-tumor functions of CCL18 at the tumor microenvironment.
Cardoso AP; Pinto ML; Castro F; Costa ÂM; Marques-Magalhães Â; Canha-Borges A; Cruz T; Velho S; Oliveira MJ
Cytokine Growth Factor Rev; 2021 Aug; 60():107-119. PubMed ID: 33863622
[TBL] [Abstract][Full Text] [Related]
10. Key chemokines direct migration of immune cells in solid tumors.
Kohli K; Pillarisetty VG; Kim TS
Cancer Gene Ther; 2022 Jan; 29(1):10-21. PubMed ID: 33603130
[TBL] [Abstract][Full Text] [Related]
11. Chemokine receptor trio: CXCR3, CXCR4 and CXCR7 crosstalk via CXCL11 and CXCL12.
Singh AK; Arya RK; Trivedi AK; Sanyal S; Baral R; Dormond O; Briscoe DM; Datta D
Cytokine Growth Factor Rev; 2013 Feb; 24(1):41-9. PubMed ID: 22989616
[TBL] [Abstract][Full Text] [Related]
12. The Multifaceted Roles of CXCL9 Within the Tumor Microenvironment.
Neo SY; Lundqvist A
Adv Exp Med Biol; 2020; 1231():45-51. PubMed ID: 32060845
[TBL] [Abstract][Full Text] [Related]
13. Chemokines orchestrate tumor cells and the microenvironment to achieve metastatic heterogeneity.
Saxena S; Singh RK
Cancer Metastasis Rev; 2021 Jun; 40(2):447-476. PubMed ID: 33959849
[TBL] [Abstract][Full Text] [Related]
14. Role of chemokines in the crosstalk between tumor and tumor-associated macrophages.
Qin R; Ren W; Ya G; Wang B; He J; Ren S; Jiang L; Zhao S
Clin Exp Med; 2023 Sep; 23(5):1359-1373. PubMed ID: 36173487
[TBL] [Abstract][Full Text] [Related]
15. Chemokines in cancer.
Chow MT; Luster AD
Cancer Immunol Res; 2014 Dec; 2(12):1125-31. PubMed ID: 25480554
[TBL] [Abstract][Full Text] [Related]
16. Conditioning solid tumor microenvironment through inflammatory chemokines and S100 family proteins.
Nasser MW; Elbaz M; Ahirwar DK; Ganju RK
Cancer Lett; 2015 Aug; 365(1):11-22. PubMed ID: 25963887
[TBL] [Abstract][Full Text] [Related]
17. Chemokines and cytokines: Axis and allies in prostate cancer pathogenesis.
Mughees M; Kaushal JB; Sharma G; Wajid S; Batra SK; Siddiqui JA
Semin Cancer Biol; 2022 Nov; 86(Pt 3):497-512. PubMed ID: 35181473
[TBL] [Abstract][Full Text] [Related]
18. Tumor microenvironment signaling and therapeutics in cancer progression.
Goenka A; Khan F; Verma B; Sinha P; Dmello CC; Jogalekar MP; Gangadaran P; Ahn BC
Cancer Commun (Lond); 2023 May; 43(5):525-561. PubMed ID: 37005490
[TBL] [Abstract][Full Text] [Related]
19. Targeting CXCL9/10/11-CXCR3 axis: an important component of tumor-promoting and antitumor immunity.
Pan M; Wei X; Xiang X; Liu Y; Zhou Q; Yang W
Clin Transl Oncol; 2023 Aug; 25(8):2306-2320. PubMed ID: 37076663
[TBL] [Abstract][Full Text] [Related]
20. Chemokines mRNA expression in relation to the Macrophage Migration Inhibitory Factor (MIF) mRNA and Vascular Endothelial Growth Factor (VEGF) mRNA expression in the microenvironment of endometrial cancer tissue and normal endometrium: a pilot study.
Giannice R; Erreni M; Allavena P; Buscaglia M; Tozzi R
Cytokine; 2013 Nov; 64(2):509-15. PubMed ID: 23985752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
